Views from a vaccine manufacturer: Q&A - Abdul Muktadir, Incepta Pharmaceuticals; Pandemic Treaty Action
Newsletter Edition #43 [The Weekly Primer]
From our partners
Striking a Balance: Standardization and Flexibility in Pandemic Contracts
Newsletter Edition #158 [Treaty Talks] Subscribe Now! Readers, Making decisions based on incomplete information is a quotidian reality for policymakers. But it is totally unwholesome to those tasked with writing
/
